A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2006
10/25/2006	EP1713510A2 Growth factor-binding compounds attached to a calixarene
10/25/2006	EP1713509A2 Method for producing conjugates of polysaccharides and polynucleotides
10/25/2006	EP1713508A2 Use of amino-oxy functional groups in the preparation of vaccine conjugates
10/25/2006	EP1713507A2 Adept or gdept production of acetaldehyde
10/25/2006	EP1713506A1 Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration
10/25/2006	EP1713505A1 Method of preparation of a fungal glucane hydrogel having antibacterial and immunostimulant activity, and use thereof
10/25/2006	EP1713504A2 Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms
10/25/2006	EP1713498A1 Composition comprising polymeric material and uses thereof
10/25/2006	EP1713476A2 Rabeprazole containing formulation
10/25/2006	EP1713468A1 Anthelmintic composition
10/25/2006	EP1713466A2 Antiparasitic composition containing an organic amine salt of closantel
10/25/2006	EP1713442A1 Semisolid matrix pharmaceutical formulations
10/25/2006	EP1713439A1 Pharmaceutical preparation for the oral cavity
10/25/2006	EP1713438A1 Medicinal soap
10/25/2006	EP1713326A1 Stabilized formulation of ivermerctin feed premix
10/25/2006	EP1524971B1 Improved transdermal delivery system
10/25/2006	EP1509231A4 Peritoneal dialysis solution with taurolidine
10/25/2006	EP1495767B1 Immunoadjuvant
10/25/2006	EP1490030B1 Nanoparticulate compositions of angiogenesis inhibitors
10/25/2006	EP1420880A4 Stabilization and terminal sterilization of phospholipid formulations
10/25/2006	EP1363951B1 Polynuclear complex fe(iii) with pullulan oligomers, process of its obtaining, and pharmaceutical preparations on the basis of the complex
10/25/2006	EP1359939B1 Composition and method for potentiating drugs
10/25/2006	EP1259250B1 Endoparasiticidal agents
10/25/2006	EP1143930B1 Pharmaceutical formulation of fluticasone propionate
10/25/2006	EP1105110B1 Spray on bandage and drug delivery system
10/25/2006	EP1079811B1 Biodegradable sustained-release alginate gels
10/25/2006	EP0983088B1 Immunpotentiating composition in a solid dosage form, having collagen or polydimethylsiloxane as a carrier substance
10/25/2006	CN1852743A Methods and devices for the treatment of intervertebral discs
10/25/2006	CN1852740A Multi-arm polymer prodrugs
10/25/2006	CN1852739A Pharmaceutical products comprising bisphosphonates
10/25/2006	CN1852733A Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
10/25/2006	CN1852727A Compositions and methods for delivering thymosin beta 4, analogues, isoforms and other derivatives
10/25/2006	CN1852721A Compositions and methods for treating, preventing and/or ameliorating cancers, the onset of cancers or the symptoms of cancers
10/25/2006	CN1852700A Triamcinolone acetonide and anecortave acetate formulations for injection
10/25/2006	CN1852687A Method for the preparation of controlled release formulations
10/25/2006	CN1850972A Sialic acid oligose-chitosan complex, and its preparing method and use
10/25/2006	CN1850844A Cholesterol derivative containing azobenzene group, and its synthesizing method and use
10/25/2006	CN1850785A N,N-dibasic glycine 3,7-dimethyl n-octyl ester, and its preparing method and use
10/25/2006	CN1850277A Gamma-polyglutaic acid-CDDP complex, and its preparing method and use
10/25/2006	CN1850276A Taxol polymer bond drug lyophilized powder injection and its preparing method
10/25/2006	CN1850275A Chiral drug intercalation hydrotalcite and its preparing method
10/25/2006	CN1850274A Nano complex eye drops containing liposoluble compound drug and its preparing method
10/25/2006	CN1850273A Transparent ointment base, and its preparing method and use
10/25/2006	CN1850107A Fatty cream composition for maligant splanchnocoele hydrops and its preparing method
10/25/2006	CN1850098A Protopanaxadiol liposome and its preparing method
10/25/2006	CN1850097A Scutellarin injection preparation and its preparing method
10/25/2006	CN1850096A Aclarubicin venous emulsion and its preparing method
10/25/2006	CN1850071A Bifendate solid dispersible, and its preparing method and low-release preparation containing same
10/25/2006	CN1850062A Fatty acid eye nano preparations for dry eye disease
10/25/2006	CN1850058A Alginate nano capsule and its preparing method
10/25/2006	CN1850055A Flunarizine hydrochloride lyophilized agent for injection and its preparing method
10/25/2006	CN1850052A Loaded vascular inhibitor and cellulutoxic drug slow-release injection
10/25/2006	CN1850051A Loaded vascular inhibitor and cellulotoxic drug anticancer slow-release injection
10/25/2006	CN1850050A Compound anticancer slow-release injection containing vascular inhibitor
10/25/2006	CN1850049A Loaded vascular inhibitor and cellulotoxic drug anticancer slow-release injection
10/25/2006	CN1850048A Anticancer slow-release injection containing vascular inhibitor
10/25/2006	CN1850047A Slow-release preparation containing beta-lactamase inhibitor and cephalosporin and its use
10/25/2006	CN1850046A Slow-release preparation containing beta-lactamase inhibitor and its use
10/25/2006	CN1850045A Slow-release preparation containing macrolides anti biotics
10/25/2006	CN1850044A Slow-release injecta containing amino glucosides antibiotics and use thereof
10/25/2006	CN1850043A Slow-release injecta containing platinums compound and its synergist
10/25/2006	CN1850042A Anti-cancer slow-release preparation containing platinum medicines and its synergist
10/25/2006	CN1850041A Anticancer medicine slow-release preparation containing platinum compound and its synergist
10/25/2006	CN1850040A Loaded platinum drug and its synergist anticancer drug slow release agent
10/25/2006	CN1850039A Compound platinum medicine slow-release preparation
10/25/2006	CN1850038A Slow-release injecta containing blood vessel inhibitor and synergist thereof
10/25/2006	CN1850037A Compound anti-cancer slow-release injected containing blood vessel inhibitor
10/25/2006	CN1850036A Slow-release preparation containing quinolones antibiotics
10/25/2006	CN1850033A Water soluble anti-cancer medicine slow-release fiber preparation and preparing method therefor
10/25/2006	CN1850032A Amphotericin B nano preparation
10/25/2006	CN1281666C Antibacterial and fungicidal polymer dispersions and polymer solutions
10/25/2006	CN1281638C Process for producton of water-soluble (method) acrylic polymers, water-soluble (meth) acrylic polymers, and use thereof
10/25/2006	CN1281630C Water soluble, randomly substituted partial N-, partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
10/25/2006	CN1281620C Transfection competent molecules
10/25/2006	CN1281287C Therapeutic film forming composition and treatment system
10/25/2006	CN1281275C Re-emulsifying carrier for homogeneous and stable hydrophilic medicine and its prepn process
10/25/2006	CN1281270C Polypeptide, the conjugate thereof with doxorubicin and a pharmaceutical composition based thereon
10/25/2006	CN1281259C Leadless plaster medium for Chinese medicine and preparing method
10/25/2006	CN1281222C Drug composition for preventing and treating prospermia and/or sexual excitation hypersensitivity
10/25/2006	CN1281217C Use of activated carbon in oral medicinal preparation for hyperthyroidism
10/25/2006	CN1281209C Stabilised oversaturated transdermal therapeutical matrix system
10/24/2006	US7125909 Sterile parenteral nutrition compositions
10/24/2006	US7125869 Drugs for cosmetics for treatment of cardiovadcular disorders, receptors, immunology or lipid metabolism
10/24/2006	US7125860 Cross-linked derivatives of hyaluronic acid
10/24/2006	US7125859 Preserving vitamins subject to oxidative damage by adding a sufficient amount of purified nucleic acid to vitamin such that the rate of oxidative damage of the vitamin is reduced
10/24/2006	US7125858 Hyaluronic acid in the treatment of cancer
10/24/2006	US7125839 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
10/24/2006	US7125696 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent
10/24/2006	US7125568 Lipophilic drug compositions
10/24/2006	US7125564 Glycyrrhizin complex
10/24/2006	US7125563 Sustained release pharmaceutical preparations and methods for producing the same
10/24/2006	US7125562 Rapidly disintegrating methylcellulose tablets
10/24/2006	US7125560 Pharmaceutical composition of topiramate
10/24/2006	US7125558 Process for the preparation of activated polyethylene glycols
10/24/2006	US7125557 Isolated haemocyanin polypeptide having a specific amino acid sequence recombinantly expressed in a host cell, wherein the glycosylation pattern is different from naturally occurring KLH from Megathura crenulata; may be bonded to a virus, bacteria, DNA, carbohydrate, peptide or glycoprotein
10/24/2006	US7125556 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin
10/24/2006	US7125554 Engineered superantigen for human therapy
10/24/2006	US7125547 Poly(diallylamine)-based bile acid sequestrants
10/24/2006	US7125546 Polymeric micelle containing cisplatin enclosed therein and use thereof
10/24/2006	US7125542 Methods and compositions for treating conditions of the eye

1 ... 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 ... 1712